Conditional inference methods for incomplete poisson data with endogenous time-varying covariates: Emergency department use among HIV-infected women

Journal of the American Statistical Association

Volumn 101, Issue 474, 2006, Pages 424-434

  Roy, Jason ^a   Alderson, Don ^b   Hogan, Joseph W ^c   Tashima, Karen T ^d  

^a UNIVERSITY OF ROCHESTER   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c Center for Statistical Sciences   (United States)

^d BROWN UNIVERSITY   (United States)

Author keywords

Conditional likelihood; Fixed effects; Incidental parameters; Longitudinal data; Nuisance parameters; Observational studies; Selection bias

Indexed keywords

EID: 33745670153     PISSN: 01621459     EISSN: None     Source Type: Journal    
DOI: 10.1198/016214505000001203     Document Type: Article

References (24)

1. Breslow, N. E., and Clayton, D. G. (1993), "Approximate Inference in Generalized Linear Mixed Models," Journal of the American Statistical Association, 88, 125-134.
2. Chen, J., Zhang, D., and Davidian, M. (2002), "A Monte Carlo EM Algorithm for Generalized Linear Mixed Models With Flexible Random-Effects Distribution," Biostatistics, 3, 347-360.
3. Davidian, M., and Giltinan, D. M. (1995), Nonlinear Mixed-Effects Models for Repeated Measurement Data, London: Chapman & Hall.
4. Fichtenbaum, C., Lee, D., Broderick, W., Emons, M., Goldberg, G., Haberman, M., and Vendiola, R. (2003), "Selected Hospital Admission Rates for Patients Who Received HAART (Abstract)," in 9th European AIDS Conference (EACS), 1st EACS Resistance & Pharmacology Workshop, October 26-29, 2003, Warsaw, Poland.
5. 3)." HIV Clinical Trials, 1, 9-16.
6. Heagerty, P. J., and Zeger, S. L. (2000). "Marginalized Multilevel Models and Likelihood Inference," Statistical Science, 15, 1-26.
7. Hernán, M. A., Brumback, B., and Robins, J. M. (2001). "Marginal Structural Models to Estimate the Joint Causal Effect of Nonrandomized Treatments," Journal of the American Statistical Association, 96, 440-448.
8. Keiser, P., Kvanli, M. E., Turner, D., Reich, J., Smith, J. W., Nassar, N. N., Gregg, C. G., and Skiest, D. J. (1999), "Protease Inhibitors Based Therapy Is Associated With Decreased HIV Related Hospital Costs," Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 20, 28-33.
9. Laird, N. M., and Ware, J. H. (1982), "Random-Effects Models for Longitudinal Data," Biometrics, 38, 963-974.
10. Lancaster, T. (2000), "The Incidental Parameter Problem Since 1948." Journal of Econometrics, 95, 391-413.
11. _ (2002), "Orthogonal Parameters and Panel Data." Review of Economic Studies, 69, 647-666.
12. Lavalle, C., Aguilar, J. C., Pena, F., Estrada-Aguilar, J. L., Avina-Zubieta, J. A., and Madrazo, M. (2000), "Reduction in Hospitalization Costs, Morbidity, Disability, and Mortality in Patients With AIDS Treated With Protease Inhibitors," Archives of Medical Research, 31, 515-519.
13. Little, R. J. A., and Rubin, D. B. (2002). Statistical Analysis With Missing Data, New York: Wiley.
14. McCullagh, P., and Nelder, J. A. (1989). Generalized Linear Models (2nd ed.). London: Chapman & Hall.
15. Neuhaus, J. M., and Kalbfleisch, J. D. (1998), "Between- and Within-Cluster Covariate Effects in the Analysis of Clustered Data," Biometrics, 54, 638-645.
16. Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., and Holmberg, S. D. (1998), "Declining Morbidity and Mortality Among Patients With Advanced Human Immunodeficiency Virus Infection," New England Journal of Medicine, 338, 853-860.
17. Palta, M., and Yao, T.-J. (1991), "Analysis of Longitudinal Data With Unmeasured Confounders," Biometrics, 47, 1355-1369.
18. Rathouz, P. J. (2004). "Fixed-Effects Models for Longitudinal Binary Data With Dropouts Missing at Random," Statistica Sinica. 14, 969-988.
19. Rathouz, P. J., Satten, G. A., and Carroll, R. J. (2002), "Semiparametric Inference in Matched Case-Control Studies With Missing Covariate Data," Binmetrika, 89, 905-916.
20. Rotnitzky, A., and Robins, J. M. (1995). "Semiparametric Regression Estimation in the Presence of Dependent Censoring," Biometrika, 82, 805-820.
21. Shapiro, M. F., Morton, S. C., McCaffrey, D. F., Semerfitt, J. W., Fleishman, J. A., Perlman, J. F., Athey, L. A., Keesey, J. W., Goldman, D. P., Berry, S. H., and Bozzette, S. A. (1999), "Variations in the Care of HIV-Infected Adults in the United States: Results From the HIV Cost and Services Utilization Study," Journal of the American Medical Association, 281, 2305-2315.
22. Smith, D. K., Warren, D. L., Vlahov, D., Schuman, P., Stein, M. D., Greenberg, B. L., and Holmberg, S. D. (1997). "Design and Baseline Participant Characteristics of the Human Immunodeficiency Virus Epidemiology Research (HER) Study: A Prospective Cohort Study of Human Immunodeficiency Virus Infection in U.S. Women," American Journal of Epidemiology, 146, 459-469.
23. Tashima, K. T., Hogan, J. W., Gardner, L. I., Korkontzelou, C. Schoenbaum, E. E., Schuman, P., Rompalo, A., and Carpenter, C. C. (2001). "A Longitudinal Analysis of Hospitalization and Emergency Department Use Among Human Immunodeficiency Virus-Infected Women Reporting Protease Inhibitor Use," Clinical Infectious Diseases, 33, 2055-2060.
24. Velasco, M. (2000), "Economic Impact of HIV Protease Inhibitor Therapy in the Global Use of Health-Care Resources," HIV Medicine, 1, 246-251.